Concert Pharmaceuticals, GlaxoSmithKline deal

Concert will receive $35 million up front, which includes a $16.7 million equity investment. Overall, Concert said it could receive over $1 billion from upfront payments and milestones from the deal. Concert is eligible for royalties from all six compounds. ...